Xiaoping Yang

10.4k citations

42 papers · 4.0k indexed · 2 hit papers · h-index 16

Impact in

Cancer Research top 1%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Molecular Biology top 2%
- RNA modifications and cancer
- RNA Research and Splicing
- CRISPR and Genetic Engineering
- Circular RNAs in diseases
- Epigenetics and DNA Methylation

Papers in ⓘ

Molecular Biology 28
- RNA and protein synthesis mechanisms 5
- CRISPR and Genetic Engineering 4
- RNA modifications and cancer 4
- Ubiquitin and proteasome pathways 4
- Cancer therapeutics and mechanisms 3
Cancer Research 8
- Cancer-related molecular mechanisms research 3

Co-authors: David E. Root (5 shared papers)Eric S. Lander (2 shared papers)Jennifer K. Grenier (2 shared papers)Ido Amit (1 shared paper)Mitchell Guttman (1 shared paper)Aviv Regev (1 shared paper)Anne Bergstrom Lucas (1 shared paper)Julie Donaghey (1 shared paper)
Journals: Nature (2 papers)Cancer Research (2 papers)The EMBO Journal (2 papers)Molecular Genetics and Genomics (1 paper)Nature Communications (1 paper)
Partner nations: China United States Germany

In The Last Decade

Xiaoping Yang

39 papers receiving 4.0k citations

Hit Papers

align trajectories log scale

lincRNAs act in the circuitry controlling pluripotency and differentiation 2011 · 1.5k citations

Peers

Countries citing papers authored by Xiaoping Yang

Since Specialization

Citations

This map shows the geographic impact of Xiaoping Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoping Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoping Yang more than expected).

Fields of papers citing papers by Xiaoping Yang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoping Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoping Yang. The network helps show where Xiaoping Yang may publish in the future.

Co-authors

The 25 scholars most cited alongside Xiaoping Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Xiaoping Yang Line = papers co-authored together Xiaoping Yang links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	lincRNAs act in the circuitry controlling pluripotency and differentiation Nature ·Mitchell Guttman, Julie Donaghey, Bryce W. Carey, Manuel Garber, Jennifer K. Grenier, Glen Munson, Geneva Young, Anne Bergstrom Lucas, Robert A. Ach, Laurakay Bruhn, Xiaoping Yang, Ido Amit, Alexander Meissner, Aviv Regev, John L. Rinn, David E. Root, Eric S. Lander Hit paper breakdown →	2011	1542
2	A Lentiviral RNAi Library for Human and Mouse Genes Applied to an Arrayed Viral High-Content Screen Cell ·Jason Moffat, Dorre A. Grueneberg, Xiaoping Yang, So Young Kim, Angela M. Kloepfer, Gregory Hinkle, Bruno Piqani, Thomas Eisenhaure, Biao Luo, Jennifer K. Grenier, Anne E. Carpenter, Shi Yin Foo, Sheila A. Stewart, Brent R. Stockwell, Nir Hacohen, William C. Hahn, Eric S. Lander, David M. Sabatini, David E. Root Hit paper breakdown →	2006	1377
3	The cell-cycle regulator geminin inhibits Hox function through direct and polycomb-mediated interactions Nature ·Lingfei Luo, Xiaoping Yang, Yoshihiro Takihara, Hendrik Knoetgen, Michael Kessel	2004	176
4	Two GTPase isoforms, Ypt31p and Ypt32p, are essential for Golgi function in yeast. The EMBO Journal ·M. Benli, Frank Döring, David G. Robinson, Xiaoping Yang, Dieter Gallwitz	1996	143
5	Characterization of tetrandrine, a potent inhibitor of P-glycoprotein-mediated multidrug resistance Cancer Chemotherapy and Pharmacology ·Liwu Fu, Yong-ju Liang, Liwen Deng, Yan Ding, Liming Chen, Yan-Li Ye, Xiaoping Yang, Qichao Pan	2004	129
6	Specific binding to a novel and essential Golgi membrane protein (Yip1p) functionally links the transport GTPases Ypt1p and Ypt31p The EMBO Journal ·Xiaoping Yang	1998	113
7	Wilms tumor 1 (WT1) regulates KRAS-driven oncogenesis and senescence in mouse and human models Journal of Clinical Investigation ·Silvestre Vicent, Chen Ron, Leanne C. Sayles, Chenwei Lin, Randal G. Walker, Anna K. Gillespie, Aravind Subramanian, Gregory Hinkle, Xiaoping Yang, Sakina Saif, David E. Root, Vicki Huff, William C. Hahn, E. Alejandro Sweet‐Cordero	2010	101
8	Antiviral effects of two Ganoderma lucidum triterpenoids against enterovirus 71 infection Biochemical and Biophysical Research Communications ·Wenjing Zhang, Junyan Tao, Xiaoping Yang, Zhuliang Yang, Li Zhang, Hongsheng Liu, Kailang Wu, Jianguo Wu	2014	89
9	The Divergence Between SARS-CoV-2 and RaTG13 Might Be Overestimated Due to the Extensive Rna Modification Future Virology ·Yue Li, Xinai Yang, Na Wang, Haiyan Wang, Bin Yin, Xiaoping Yang, Wenqing Jiang	2020	35
10	GC usage of SARS-CoV-2 genes might adapt to the environment of human lung expressed genes Molecular Genetics and Genomics ·Yue Li, Xinai Yang, Na Wang, Haiyan Wang, Bin Yin, Xiaoping Yang, Wenqing Jiang	2020	31
11	In Vivo Gene Delivery and Visualization of Corneal Stromal Cells Using an Adenoviral Vector and Keratocyte-Specific Promoter Investigative Ophthalmology & Visual Science ·Eric J. Carlson, Chia‐Yang Liu, Xiaoping Yang, Meredith S. Gregory, Bruce R. Ksander, Judith Drazba, Víctor Pérez	2004	31
12	Prevention of PathogenicEscherichia coliInfection in Mice and Stimulation of Macrophage Activation in Rats by an Oral Administration of ProbioticLactobacillus caseiI-5 Bioscience Biotechnology and Biochemistry ·Keiko Ishida‐Fujii, Rieko Sato, Shingo Goto, Xiaoping Yang, Hiroshi Kuboki, Shin‐ichi Hirano, Michikatsu Sato	2007	29
13	Potential protection of 2,3,5,4′-tetrahydroxystilbene-2-O-β-d-glucoside against staurosporine-induced toxicity on cultured rat hippocampus neurons Neuroscience Letters ·Xiaoping Yang, Taoyan Liu, Xiao‐Yan Qin, Long‐Chuan Yu	2014	24
14	RB has a critical role in mediating the in vivo checkpoint response, mitigating secondary DNA damage and suppressing liver tumorigenesis initiated by aflatoxin B1 Oncogene ·Chris Reed, Christopher N. Mayhew, A. Kathleen McClendon, Xiaoping Yang, Agnieszka K. Witkiewicz, Erik S. Knudsen	2009	22
15	Comparative optimization of combinatorial CRISPR screens Nature Communications ·Ruitong Li, Olaf Klingbeil, Davide Monducci, Michael J. Young, Diego J. Rodriguez, Zaid Bayyat, Joshua M. Dempster, Devishi Kesar, Xiaoping Yang, Mahdi Zamanighomi, Christopher R. Vakoc, Takahiro Ito, William R. Sellers	2022	20
16	Targeted next generation sequencing in 112 Chinese patients with intellectual disability/developmental delay: novel mutations and candidate gene BMC Medical Genetics ·Huifang Yan, Zhen Shi, Ye Wu, Jiangxi Xiao, Qiang Gu, Yanling Yang, Ming Li, Kai Gao, Yinyin Chen, Xiaoping Yang, Haoran Ji, Binbin Cao, Ruoyu Duan, Yuwu Jiang, Jingmin Wang	2019	16
17	Mutation Profile of Over 4500 SARS-CoV-2 Isolations Reveals Prevalent Cytosine-to-Uridine Deamination on Viral RNAs Future Microbiology ·Yue Li, Xinai Yang, Na Wang, Haiyan Wang, Bin Yin, Xiaoping Yang, Wenqing Jiang	2020	14
18	C-to-U RNA deamination is the driving force accelerating SARS-CoV-2 evolution Life Science Alliance ·Yan Li, Fanghua Hou, Meili Zhou, Xiaoping Yang, Bin Yin, Wenqing Jiang, Huiqing Xu	2022	11
19	Human Sulfatase-1 Improves the Effectiveness of Cytosine Deaminase Suicide Gene Therapy with 5-Fluorocytosine Treatment on Hepatocellular Carcinoma Cell Line HepG2 In Vitro and In Vivo Chinese Medical Journal ·Xiaoping Yang, Ling Liu, Ping Wang, Shenglin Ma	2015	11
20	SARS-CoV-2 competes with host mRNAs for efficient translation by maintaining the mutations favorable for translation initiation Journal of Applied Genetics ·Yanping Zhang, Xiaojie Jin, Haiyan Wang, Yaoyao Miao, Xiaoping Yang, Wenqing Jiang, Bin Yin	2021	11

About Xiaoping Yang

Xiaoping Yang is a scholar working on Molecular Biology, Cancer Research, Oncology, Immunology and Infectious Diseases, having authored 42 papers that have together received 4.0k indexed citations. Recurring topics across this work include RNA and protein synthesis mechanisms (5 papers), CRISPR and Genetic Engineering (4 papers), Viral Infections and Immunology Research (4 papers), RNA modifications and cancer (4 papers), interferon and immune responses (4 papers), Ubiquitin and proteasome pathways (4 papers), Cancer therapeutics and mechanisms (3 papers) and Cancer-related molecular mechanisms research (3 papers). The work is most often cited by research in Cancer Research (1.5k citations), Molecular Biology (3.3k citations), Cell Biology (442 citations), Aging (26 citations) and Oncology (404 citations). Xiaoping Yang has collaborated with scholars based in China, United States and Germany. Frequent co-authors include David E. Root, Eric S. Lander, Jennifer K. Grenier, Ido Amit, Mitchell Guttman, Aviv Regev, Anne Bergstrom Lucas, Julie Donaghey, Geneva Young and Robert A. Ach. Their work appears in journals such as Nature, Cancer Research, The EMBO Journal, Molecular Genetics and Genomics and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact